Endometrial wave direction switch and the outcome of in vitro fertilization

Fertil Steril. 1999 Mar;71(3):476-81. doi: 10.1016/s0015-0282(98)00501-9.

Abstract

Objective: To describe endometrial wavelike activity, endometrial thickness and texture in IVF cycles, and to relate them to IVF outcome. To evaluate wave patterns on the day of hCG administration as a predictor of IVF outcome.

Design: Ultrasound study.

Setting: University hospital-based infertility clinic.

Patient(s): Twenty-eight women undergoing IVF.

Intervention(s): Ultrasound examinations were performed at five fixed moments (start ovarian stimulation, hCG administration, ovum pickup (OPU), ET, and 7 days after hCG administration) and at three variable moments in the stimulation period in the cycle. The OPU was performed 2 days after hCG administration; ET was performed 2 or 3 days after that.

Main outcome measure(s): Endometrial wave pattern, thickness, texture, IVF outcome.

Result(s): Embryo transfer was performed in 22 cycles. In 73% of the cycles a wave direction switch (WDS) from fundus to cervix (FC) to cervix to fundus (CF) occurred before OPU. Eleven (50%) patients became pregnant. Significantly more FC waves persisted until hCG administration in the cycles in which the patients conceived. Endometrial thickness and texture were unrelated to IVF outcome.

Conclusion(s): Endometrial wave pattern is associated with pregnancy in IVF. The persisting presence of FC waves until hCG administration (a late WDS) predicts a favorable IVF outcome.

MeSH terms

  • Adult
  • Chorionic Gonadotropin / therapeutic use
  • Embryo Transfer
  • Endometrium / diagnostic imaging*
  • Endometrium / drug effects
  • Endometrium / pathology
  • Female
  • Fertilization in Vitro*
  • Follicle Stimulating Hormone / therapeutic use
  • Follicle Stimulating Hormone, Human
  • Follicular Phase*
  • Hormones / therapeutic use
  • Humans
  • Luteal Phase
  • Nafarelin / therapeutic use
  • Pregnancy
  • Pregnancy Rate
  • Prospective Studies
  • Recombinant Proteins / therapeutic use
  • Ultrasonography

Substances

  • Chorionic Gonadotropin
  • Follicle Stimulating Hormone, Human
  • Hormones
  • Recombinant Proteins
  • Nafarelin
  • Follicle Stimulating Hormone